-
公开(公告)号:US11603363B2
公开(公告)日:2023-03-14
申请号:US17322409
申请日:2021-05-17
Applicant: Novartis AG
Inventor: Zichen Jia , Philipp Lustenberger , Marie Meyer , Massimo Moratto
IPC: C07D401/06
Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.